Months of Growth: This Glorious Growth Stock Could Soar
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Articles — Page 1303
Real Estate ETFs: REET for Global Diversification and Income
Real estate ETFs give you exposure to property markets without being a landlord. This guide compares REET and VNQ, fo...
Why This Investor Million More on Packaging Lagging S&P
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
Carnival Earnings Anxiety: Good, Bad, Ugly for Investors
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Real Estate ETFs with Global Reach: HAUZ vs ICF in Focus
Two real estate ETFs take opposite paths: one spreads bets worldwide, the other bets on the U.S. market. Learn how HA...
Why Your Could Rapidly Include SpaceX in an S&P 500 ETF Soon
Huge IPO rumors around SpaceX could change the way S&P 500 ETFs are built. This guide explains how inclusion works, w...
Tokenized Assets: DeFi’s Biggest Unlock for Markets
DeFi founders argue that tokenized assets are the next growth lever, linking real-world value to on-chain liquidity. ...
Bitcoin No Longer a High-Beta Play, QCP Warns
Bitcoin shows signs of shifting away from high-beta behavior, yet it has not become a reliable safe haven, according ...
Playnance Puts Coin Presale on Track for March 18 Debut
Playnance launches the G Coin presale on March 18, positioning the token as the utility layer for an ecosystem with h...
Trump Administration Just Rewarded Archer and Joby: Winners?
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
General Mills (GIS) 2026: Earnings Outlook and Strategy
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...